[Federal Register Volume 76, Number 141 (Friday, July 22, 2011)]
[Notices]
[Page 43993]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-18524]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Notice of Availability for Exclusive, Non-Exclusive, or 
Partially-Exclusive Licensing of an Invention Concerning Method of 
Diagnosing of Exposure to Toxic Agents by Measuring Distinct Pattern in 
the Levels of Expression of Specific Genes

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in U.S. Patent 6,316,197, entitled ``Method of 
Diagnosing of Exposure to Toxic Agents by Measuring Distinct Pattern in 
the Levels of Expression of Specific Genes,'' issued November 13, 2001. 
The United States Government, as represented by the Secretary of the 
Army, has rights to this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Applications (ORTA), (301) 619-
6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to a method of 
diagnosing exposure to a toxic agent by determining a difference in the 
detected amount of protein/gene expression between exposed and 
unexposed samples.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2011-18524 Filed 7-21-11; 8:45 am]
BILLING CODE 3710-08-P